Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI)-NCC Group plc
-
READ Launches Multilingual Language Learning Hub to Simplify English and Manglish Learning in Malaysia
-
New Earth Resources Applauds U.S. Department of Energy Nuclear Lifecycle Innovation Campus Initiative
-
Kalmar’s January–December 2025 financial statements review to be published on Friday, 13 February 2026
-
Riikka Tieaho appointed Executive Vice President, Sustainability, Corporate Affairs & Legal, and General Counsel
-
Offentliggørelse af prospekt for Investeringsforeningen Nordea Invest
-
Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
-
Orion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026
-
Government of Liberia and ArcelorMittal sign new long-term Mineral Development Agreement
-
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
-
TCM Group A/S: Major shareholder announcement
-
Diversified Energy TR-1
-
NBPE Announces December Monthly NAV Estimate
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
Q3 update for the three months ended 31 October 2025
-
Transaction in Own Shares
-
Board Update
-
AKVA group ASA: Invitation – presentation of the Q4 2025 financial results
-
China Advances Undersea Tunnel Projects with Homegrown Technology
-
Sampo plc’s share buybacks 29 January 2026
-
Start of Day Message
-
MAISONS DU MONDE: Q4 25 AND FY25 SALES
-
Idorsia to present long-term lucerastat data and kidney biopsy results at WORLDSymposium
-
Signify reports full-year 2025 sales of EUR 5.8 billion, operational profitability of 8.9% and a free cash flow of EUR 440 million
-
December 2025 Quarterly Activities Report
-
December 2025 Quarterly Activities Report
-
Vaxcyte Announces Pricing of $550 Million Public Offering
-
CGTN: Beyond differences: Why the British PM calls long-awaited China trip a 'huge opportunity'
-
CGTN: Beyond differences: Why the British PM calls long-awaited China trip a 'huge opportunity'
-
Chinese RISC-V Chipmaker SpacemiT Launches K3 AI CPU, Highlighting the Rise of Open-Source Hardware in Intelligent Computing
-
Shanghai Launches "Spring Festival Gift Packs" with Discounts and Cultural Experiences for the Chinese Lunar New Year
-
Shanghai Launches "Spring Festival Gift Packs" with Discounts and Cultural Experiences for the Chinese Lunar New Year
-
Together Forward Capital Management Inc. (TF) Outlines Collaboration Strategy in Annual Report; Plans to Advance Synergy with AgriTech Firms
-
Bombardier Statement
-
Anfield Energy Amends Credit Facility with Extract
-
Mission Success: Rocket Lab Launches Korean Earth-Imaging Satellite, Completes 2nd Launch in 8 Days
-
Kyivstar Group Ltd. Announces Pricing of Secondary Offering of Common Shares
-
Kyivstar Announces Pricing of Secondary Offering of Common Shares Held by VEON
-
M EVO GLOBAL ACQUISITION CORP II Announces Pricing of Upsized $270 Million Initial Public Offering
-
Muzero Acquisition Corp Announces the Pricing of $175 Million Initial Public Offering
-
Global Launch of iCAUR V27 in Dubai: The Classic New-Energy Boxy SUV Sets Off on Its Worldwide Journey!
-
Bodor Laser Introduces the “Extreme Speed” Concept in Tube Processing, Launches the SK Series High-Speed Tube Laser Cutting Machine
-
Johnson Outdoors Inc. Annual Shareholders Meeting
-
National Minority Quality Forum Launches COVID Care Club, a New Patient Network Addressing COVID-19, Long COVID, and the Ongoing Impact of Misinformation
-
FireFly set to capitalise on strong copper outlook with economic studies underway
-
authID and MajorKey Selected by Global Retailer to Deliver High-Assurance Identity Onboarding and Privileged Access Protection
-
Columbia Financial, Inc. Announces Promotion of Dennis E. Gibney to First Senior Executive Vice President and Chief Banking Officer
-
Newbridge Acquisition Limited Announces Pricing of $50 Million Initial Public Offering
-
MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
